With effect from 11 June 2024
Biocon has approved the appointment of Mukesh Kamath, Head - Business Finance R&D, as the Interim Chief Financial Officer and Key Managerial Personnel of the Company with effect from 11 June 2024 till the time new CFO is appointed by the Board.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
